Back to Search Start Over

Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation

Authors :
Strawbridge, R.J.
Silveira, A.
Hoed, M. den
Gustafsson, S.
Luan, J.A.
Rybin, D.
Dupuis, J.
Li-Gao, R.F.
Kavousi, M.
Dehghan, A.
Haljas, K.
Lahti, J.
Gadin, J.R.
Backlund, A.
Faire, U. de
Gertow, K.
Giral, P.
Goel, A.
Humphries, S.E.
Kurl, S.
Langenberg, C.
Lannfelt, L.L.
Lind, L.
Lindgren, C.C.M.
Mannarino, E.
Mook-Kanamori, D.O.
Morris, A.P.
Mutsert, R. de
Rauramaa, R.
Saliba-Gustafsson, P.
Sennblad, B.
Smit, A.J.
Syvanen, A.C.
Tremoli, E.
Veglia, F.
Zethelius, B.
Bjorck, H.M.
Eriksson, J.G.
Hofman, A.
Franco, O.H.
Watkins, H.
Jukema, J.W.
Florez, J.C.
Wareham, N.J.
Meigs, J.B.
Ingelsson, E.
Baldassarre, D.
Hamsten, A.
IMPROVE Study Grp
Medicum
Department of Psychology and Logopedics
University of Helsinki
Clinicum
Johan Eriksson / Principal Investigator
Department of General Practice and Primary Health Care
Developmental Psychology Research Group
Luan, Jian'an [0000-0003-3137-6337]
Langenberg, Claudia [0000-0002-5017-7344]
Wareham, Nicholas [0000-0003-1422-2993]
Apollo - University of Cambridge Repository
Source :
Atherosclerosis, 266, 196-204
Publication Year :
2017

Abstract

Background and aims: Increased proinsulin relative to insulin levels have been associated with subclinical atherosclerosis (measured by carotid intima-media thickness (cIMT)) and are predictive of future cardiovascular disease (CVD), independently of established risk factors. The mechanisms linking proinsulin to atherosclerosis and CVD are unclear. A genome-wide meta-analysis has identified nine loci associated with circulating proinsulin levels. Using proinsulin-associated SNPs, we set out to use a Mendelian randomisation approach to test the hypothesis that proinsulin plays a causal role in subclinical vascular remodelling. Methods: We studied the high CVD-risk IMPROVE cohort (n = 3345), which has detailed biochemical phenotyping and repeated, state-of-the-art, high-resolution carotid ultrasound examinations. Genotyping was performed using Illumina Cardio-Metabo and Immuno arrays, which include reported proinsulin-associated loci. Participants with type 2 diabetes (n = 904) were omitted from the analysis. Linear regression was used to identify proinsulin-associated genetic variants. Results: We identified a proinsulin locus on chromosome 15 (rs8029765) and replicated it in data from 20,003 additional individuals. An 11-SNP score, including the previously identified and the chromosome 15 proinsulin-associated loci, was significantly and negatively associated with baseline IMTmean and IMTmax (the primary cIMT phenotypes) but not with progression measures. However, MR-Eggers refuted any significant effect of the proinsulin-associated 11-SNP score, and a non-pleiotropic SNP score of three variants (including rs8029765) demonstrated no effect on baseline or progression cIMT measures. Conclusions: We identified a novel proinsulin-associated locus and demonstrated that whilst proinsulin levels are associated with cIMT measures, proinsulin per se is unlikely to have a causative effect on cIMT. (C) 2017 The Authors. Published by Elsevier Ireland Ltd.

Details

Language :
English
Database :
OpenAIRE
Journal :
Atherosclerosis, 266, 196-204
Accession number :
edsair.dedup.wf.001..cf77c713ac918ebc0237764ddb5e7492